We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
The Government Chemist team have published a report summarising the findings of a ring trial to assess laboratories’ performance in measuring CBD and controlled cannabinoids
The VMD considers that veterinary products containing Cannabidiol are veterinary medicines.
Letter from Kit Malthouse MP to Professor Owen Bowden-Jones, Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Joint VMD and Veterinary Products Committee (VPC) open information day on Wednesday 18 November.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.